Gemifioxacin

CAS : 175463-14-6

Ref. 3D-FG103934

Informations sur le produit

• Nom: Gemifioxacin
• Synonymes: 1,8-Naphthyridine-3-carboxylic acid, 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, 7-(3-Aminomethyl)-4-Methoxyimino-Pyrrolidin-1-Yl)-1-Cyclopropyl-6-Fluoro-4-Oxo-1, 4-Dihydro-[1, 8]Naphthyridine-3-Carboxylic Acid, 7-3(Aminomethyl-4-(Z)-methoxyimino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthylridine-3-carboxylic acid, 7-[(4E)-3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate, 7-[(4Z)-3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, 7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid Mesilate, Gemifloxacin, Lb 20304, Sb 265805
• CAS: 175463-14-6

Description

Gemifioxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, which are enzymes that maintain the integrity of bacterial DNA. Gemifioxacin has been shown to be useful in the treatment of acute bacterial rhinosinusitis caused by gram-positive bacteria such as Streptococcus pneumoniae and Staphylococcus aureus. This drug can cause protein oxidation and may have interactions with other drugs. Gemifloxacin is not active against gram-negative bacteria such as Escherichia coli or Klebsiella pneumoniae.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 389.38 g/mol
• Formule: C₁₈H₂₀FN₅O₄
• Degré de pureté: Min. 95%